Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective StrategyAnthony R. Mato, Colleen Dorsey, Danielle M. Brander et al.|Clinical Cancer Research|2020Cited by 115
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agentsLindsey E. Roeker, Anthony R. Mato, Peter Dreger et al.|Blood Advances|2020Cited by 86
Consolidation (Cons) and maintenance (Maint) approaches in primary central nervous system lymphoma (PCNSL) after high-dose methotrexate induction in transplant-ineligible patientsYun Kyoung Tiger, Venkata Preetam Sandeep Kaduluri, Taylor Kujawa et al.|Blood|2025Cited by 0